Join Growin Stock Community!
Back to AKTS.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

revenue-chart

AKTS Revenue

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

Aktis oncology, inc. (AKTS) 2025Q1 financial report shows revenue of 9.03M USD, with a YoY growth rate of 28.92%. This data clearly demonstrates significant revenue growth, with the company showing strong operational momentum and a marked increase in market demand. To fully capture future growth potential and investment opportunities, investors should closely monitor Aktis oncology, inc. (AKTS)’s upcoming financial reports and key strategic adjustments, and leverage diversified data analysis, especially advanced tools like Growin AI Value Analysis, for a comprehensive and forward-looking evaluation.